BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24615200)

  • 1. [Granulomatous pneumonia as a complication of intravesical BCG immunotherapy--a case report].
    Rogoziński P; Taracha-Guz D; Pęcikiewicz P; Kachel T; Dubiel G; Wandzel P; Bruliński K
    Pneumonol Alergol Pol; 2014; 82(2):163-9. PubMed ID: 24615200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
    Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
    Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Granulomatous prostatitis after intravesical BCG immunotherapy of superficial bladder cancer: a case report].
    Sai S; Sakakibara T; Takashi M; Sakata T; Miyake K
    Hinyokika Kiyo; 1990 Aug; 36(8):953-5. PubMed ID: 2239600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulomatous hepatitis as a complication of intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma.
    Arzt MR; Forouhar F
    Ann Clin Lab Sci; 1995; 25(5):409-13. PubMed ID: 7486816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Case of Granulomatous Pneumonitis Due to Intravesical BCG for Bladder Cancer.
    Clérigo V; Castro A; Mourato T; Gomes C
    Acta Med Port; 2019 Apr; 32(4):316-320. PubMed ID: 31067427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.
    Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
    Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated pulmonary granulomas after intravesical bacillus Calmette-Guérin immunotherapy.
    De Diego A; Rogado MC; Prieto M; Nauffal D; Perpiñá M
    Respiration; 1997; 64(4):304-6. PubMed ID: 9257368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
    Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
    Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma.
    Nadasy KA; Patel RS; Emmett M; Murillo RA; Tribble MA; Black RD; Sutker WL
    South Med J; 2008 Jan; 101(1):91-5. PubMed ID: 18176300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Miliary Pulmonary Tuberculosis After Intravesical BCG Instillation in a Patient with High-Grade Bladder Cancer].
    Gözüküçük R; Çakıroğlu B
    Mikrobiyol Bul; 2023 Oct; 57(4):675-681. PubMed ID: 37885395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy.
    Gonzalez OY; Musher DM; Brar I; Furgeson S; Boktour MR; Septimus EJ; Hamill RJ; Graviss EA
    Clin Infect Dis; 2003 Jan; 36(2):140-8. PubMed ID: 12522745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case Diagnosed as Iatrogenic Vesical Tuberculosis 4 Years after Intravesical Immunotherapy Using Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Carcinoma].
    Kudo T; Iwasa N; Maeda S; Mitarai S
    Kansenshogaku Zasshi; 2016 Nov; 90(6):809-13. PubMed ID: 30277373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma.
    Larsen BT; Smith ML; Grys TE; Vikram HR; Colby TV
    Int J Surg Pathol; 2015 May; 23(3):189-95. PubMed ID: 25614462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
    Pommier JD; Ben Lasfar N; Van Grunderbeeck N; Burdet C; Laouénan C; Rioux C; Pierre-Audigier C; Meybeck A; Choudat L; Benchikh A; Nguyen S; Bouvet E; Yeni P; Yazdanpanah Y; Joly V
    Infect Dis (Lond); 2015; 47(10):725-31. PubMed ID: 26077036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer.
    Bajramovic S; Alic J; Skopljak E; Chikha A; Vesnic S; Smajilbegovic V; Aganovic D
    Med Arch; 2020 Apr; 74(2):146-150. PubMed ID: 32577059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Granulomatous hepatitis revealing a Mycobacterium bovis widespread infection following intravesical BCG therapy].
    Raffray L; Rivière P; Bonnet H; Duffau P; Longy-Boursier M
    Rev Med Interne; 2015 Sep; 36(9):626-30. PubMed ID: 25467298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.
    Leebeek FW; Ouwendijk RJ; Kolk AH; Dees A; Meek JC; Nienhuis JE; Dingemans-Dumas AM
    Gut; 1996 Apr; 38(4):616-8. PubMed ID: 8707098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin immunotherapy.
    Hoag N; Pommerville PJ; Kibsey PC; Cavers DJ; Eddy RJ
    Can J Urol; 2009 Apr; 16(2):4589-91. PubMed ID: 19364433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal aortic aneurysmal and endovascular device infection with iliopsoas abscess caused by Mycobacterium bovis as a complication of intravesical bacillus Calmette-Guérin therapy.
    Mizoguchi H; Iida O; Dohi T; Tomoda K; Kimura H; Inoue K; Iwata T; Tei K; Miura T
    Ann Vasc Surg; 2013 Nov; 27(8):1186.e1-5. PubMed ID: 23972639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal tuberculosis with severe neurological symptoms as a complication of intravesical BCG therapy for carcinoma of the bladder.
    Białecki J; Nowak-Misiak M; Rąpała K; Marczyński W; Suchodolski G; Truszczyńska A
    Neurol Neurochir Pol; 2016; 50(2):131-8. PubMed ID: 26969570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.